Rapport Therapeutics IPO Price Indicating $18 On 163K Shares
Portfolio Pulse from Benzinga Newsdesk
Rapport Therapeutics is set to price its IPO at $18 per share, with 163,000 shares being offered.
June 07, 2024 | 2:24 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Rapport Therapeutics is pricing its IPO at $18 per share, offering 163,000 shares. This could attract investor interest and potentially drive the stock price up in the short term.
The IPO pricing at $18 per share and the offering of 163,000 shares is likely to generate investor interest, which could lead to a positive short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100